Back

Pulmonary vein isolation in obese vs. non-obese patients: insights from the German national DRG-Database

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: important clinical questions Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Vera Maslova

University Medical Center of Schleswig-Holstein, Kiel (Germany)

7 More presentations in this session

Presentation thumbnail
Procedural characteristics, extent of acute antral lesion size, and myocardial injury with two different pulsed field ablation systems - the dual pulse system study
Doctor B. Subin (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of extended pulsed-field ablation in persistent atrial fibrillation.
Doctor H. Alarcos Blasco (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Outcomes of catheter ablation of atrial fibrillation in African American patients
Assistant Professor A. Maan (Toledo, US)
Abstract Slides Video
Presentation thumbnail
Left atrial size is a critical factor for selection of the optimal catheter ablation system for pulmonary vein isolation - pulsed field ablation or cryoballoon?
Doctor P. Kahle (Bad Nauheim, DE)
Abstract Slides Video
Presentation thumbnail
Feasibility and safety of pulsed-field ablation for mitral isthmus in persistent atrial fibrillation
Doctor H. Alarcos Blasco (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: important clinical questions

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Hemodynamic and respiratory stability in obese vs. non-obese patients during de novo pulmonary vein isolation under conscious sedation
thumbnail
Congress Presentation
Evaluation of effectiveness and outcomes of pulsed field ablation of atrial fibrillation in patients with obesity
thumbnail
Congress Presentation
1 year clinical & safety outcome of obese patients undergoing PVI for atrial fibrillation with pulsed field or cryoballoon ablation - a prospensity matched analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources